Cannabinoid type 2 receptor activation inhibits MPP+-induced M1 differentiation of microglia through activating PI3K/Akt/Nrf2 signal pathway

  • Forno LS (1996) Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55:259–272

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Skaper SD, Giusti P, Facci L (2012) Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J 26:3103–3117

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kam TI, Hinkle JT, Dawson TM, Dawson VL (2020) Microglia and astrocyte dysfunction in Parkinson’s disease. Neurobiol Dis 144:105028

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sugama S, Takenouchi T, Cho BP, Joh TH, Hashimoto M, Kitani H (2009) Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflamm Allergy Drug Targets 8:277–284

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6:13

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cassano T, Calcagnini S, Pace L, De Marco F, Romano A, Gaetani S (2017) Cannabinoid receptor 2 signaling in neurodegenerative Disorders: from pathogenesis to a Promising Therapeutic Target. Front Neurosci 11:30

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lisboa SF, Gomes FV, Guimaraes FS, Campos AC (2016) Microglial cells as a link between Cannabinoids and the Immune Hypothesis of Psychiatric Disorders. Front Neurol 7:5

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tao Y, Li L, Jiang B, Feng Z, Yang L, Tang J, Chen Q, Zhang J, Tan Q, Feng H, Chen Z, Zhu G (2016) Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model. Brain Behav Immun 58:118–129

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhao Y, Zhang Q, Xi J, Xiao B, Li Y, Ma C (2015) Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/beta-catenin dependent pathways in a mice model of Parkinson’s disease. Int J Clin Exp Pathol 8:2354–2364

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Galan-Ganga M, Del Rio R, Jimenez-Moreno N, Diaz-Guerra M, Lastres-Becker I (2020) Cannabinoid CB2 receptor modulation by the transcription factor NRF2 is specific in Microglial cells. Cell Mol Neurobiol 40:167–177

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • de Oliveira MR, Ferreira GC, Schuck PF (2016) Protective effect of carnosic acid against paraquat-induced redox impairment and mitochondrial dysfunction in SH-SY5Y cells: role for PI3K/Akt/Nrf2 pathway. Toxicol In Vitro 32:41–54

    Article 
    PubMed 

    Google Scholar
     

  • Wu Q, Ma Y, Liu Y, Wang N, Zhao X, Wen D (2020) CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2/HO-1 pathway in diet-induced obese mice. Life Sci 260:118424

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Popiolek-Barczyk K, Rojewska E, Jurga AM, Makuch W, Zador F, Borsodi A, Piotrowska A, Przewlocka B, Mika J (2014) Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain. Biomed Res Int 2014:762930

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhao S, Wang M, Ma Z (2021) Therapeutic potential of ATP-sensitive potassium channels in Parkinson’s disease. Brain Res Bull 169:1–7

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • More SV, Kumar H, Kim IS, Song SY, Choi DK (2013) Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s disease, Mediators Inflamm, Doi 10.1155/2013/952375

    Article 

    Google Scholar
     

  • Lu Y, Zhou M, Li Y, Li Y, Hua Y, Fan Y (2021) Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1/STAT6 pathways. Biochem Pharmacol 186:114464

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Du RH, Sun HB, Hu ZL, Lu M, Ding JH, Hu G (2018) Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease. Cell Death Dis 9:404

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Castillo PE, Younts TJ, Chavez AE, Hashimotodani Y (2012) Endocannabinoid signaling and synaptic function. Neuron 76:70–81

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Javed H, Azimullah S, Haque ME, Ojha SK (2016) Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease. Front Neurosci 10:321

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gubellini P, Kachidian P (2015) Animal models of Parkinson’s disease: an updated overview. Rev Neurol (Paris) 171:750–761

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • He Q, Wang Q, Yuan C, Wang Y (2017) Downregulation of mir-7116-5p in microglia by MPP(+) sensitizes TNF-alpha production to induce dopaminergic neuron damage. Glia 65:1251–1263

    Article 
    PubMed 

    Google Scholar
     

  • Huang H, Gao Y, Nie K, Wang L (2021) [Macrophage migration inhibitory factor meditates MPP+/MPTP-induced NLRP3 inflammasome activation in microglia cells]. Nan Fang Yi Ke Da Xue Xue Bao 41:972–979

    CAS 
    PubMed 

    Google Scholar
     

  • Zhou P, Weng R, Chen Z, Wang R, Zou J, Liu X, Liao J, Wang Y, Xia Y, Wang Q (2016) TLR4 Signaling in MPP(+)-Induced Activation of BV-2 Cells, Neural Plast https://doi.org/10.1155/2016/5076740

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ma L, Jia J, Liu X, Bai F, Wang Q, Xiong L (2015) Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling. Biochem Biophys Res Commun 458:92–97

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Dong W, Luo B, Qiu C, Jiang X, Shen B, Zhang L, Liu W, Zhang W (2020) TRIM3 attenuates apoptosis in Parkinson’s disease via activating PI3K/AKT signal pathway. Aging 13:735–749

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li J, Cheng X, Fu D, Liang Y, Chen C, Deng W, He L (2022) Autophagy of spinal Microglia affects the activation of Microglia through the PI3K/AKT/mTOR signaling pathway. Neuroscience 482:77–86

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhong Y, Cai X, Ding L, Liao J, Liu X, Huang Y, Chen X, Long L (2022) Nrf2 inhibits the progression of Parkinson’s disease by upregulating AABR07032261.5 to repress pyroptosis. J Inflamm Res 15:669–685

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Subedi L, Lee JH, Yumnam S, Ji E, Kim SY (2019) Anti-inflammatory effect of sulforaphane on LPS-Activated Microglia potentially through JNK/AP-1/NF-kappaB inhibition and Nrf2/HO-1 activation, Cells 8(2): 194

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liao S, Wu J, Liu R, Wang S, Luo J, Yang Y, Qin Y, Li T, Zheng X, Song J, Zhao X, Xiao C, Zhang Y, Bian L, Jia P, Bai Y, Zheng X (2020) A novel compound DBZ ameliorates neuroinflammation in LPS-stimulated microglia and ischemic stroke rats: role of akt(Ser473)/GSK3beta(Ser9)-mediated Nrf2 activation. Redox Biol 36:101644

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang N, Nie H, Zhang Y, Han H, Wang S, Liu W, Tian K (2022) Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway. Inflamm Res 71:93–106

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Read more here: Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *